|
SMITH & NEPHEW, INC. LGN COCR CONSTRAINED FEM 6 RT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
|
Back to Search Results |
|
| Catalog Number |
71426006 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Peripheral Nervous Injury (4414); Non-malignant Neoplasm (4842)
|
| Date of Event |
02/01/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H3, h6: internal reference number: (b)(4).This complaint was opened by smith+nephew to document a patient complication identified through the review of clinical evidence from post market clinical data collection activities that includes reference to the use of a smith+nephew product.The reported issue(s) relate to known inherent procedural risks that are appropriately documented in our risk files.Smith+nephew will continue to monitor trends in accordance with our post-market surveillance process and take necessary action as required if anticipated severity and/or occurrence rates are exceeded.Smith+nephew has no reason to suspect that the product failed to meet any specifications at the time of manufacture.Based on our review of all currently available information, we are unable to confirm a relationship between the reported event and the device or identify a definitive root cause.However, as the use of our product cannot be excluded as a potential cause or contributory factor to the reported issue, we are conservatively submitting this report in accordance with applicable regulations.If additional information becomes available that alters the conclusions of this report, a follow-up report will be submitted as required.¿.
|
| |
|
Event or Problem Description
|
|
It was reported that patient underwent a right 2-stage revision tka surgery in 2018 due to an infection.During the revision surgery, legion/gii smith & nephew component(s) were implanted.On (b)(6) 2020, the patient experienced a right knee neuroma that required excision.This information was collected retrospectively as part of a post-market clinical follow up activity and is provided in an anonymized format; therefore, no further information available.
|
| |
|
Search Alerts/Recalls
|
|
|